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Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is a hereditary cardiomyopathy that is 
histologically characterized by progressive replacement of the right ventricular myocardial tissue by 
fibrofatty tissue and usually manifests from the second to fourth decade of life with ventricular ar-
rhythmias origin from the right ventricle, sudden cardiac death and / or abnormal contractility of the 
right ventricle. Today, it is known that this replacement of normal myocardial of RV with fibrofatty tis-
sues the result of the mutation of five genes encoding heart desmosome proteins responsible for con-
necting cardiomyocytes.1-4 Typical morphological features of ARVC are regional contractility disor-
ders, aneurysm, or dyssynchrony of the right ventricle contractions. These abnormalities are typically 
observed in predilection areas involving the subtricuspidal area, the free wall of basal segment RV and 
the posterolateral wall of LV. The 2010 Revised Task Force criteria for ARVD clearly highlighted the 
importance of cardiovascular imaging in diagnosing this clinical entity, primarily keeping in mind 
2D echocardiography and cardiac magnetic resonance. They have become widely available, especially 
2D echocardiography, are non-invasive and do not expose patients to ionizing radiation. Although not 
included in the diagnostic criteria, studies confirm that echocardiographic imaging methods using a 
TDI or speckle tracking are tool which allow us to notice early changes in RV function. Cardiac mag-
netic resonance has the ability of 3D visualization and high spatial resolution, and also provides both 
morphological and functional characterization as well as estimation of fibrofatty replacement, and is 
the gold standard for final diagnosis, while 2D echocardiography serves in clinical follow-up and has 
shown significant variability in the rate of progression disease.
